Skip to main content

Table 3 Correlation with clinicopathologic characteristics of the patients and immunostaining of ANXA4 and FLNA (n = 94)

From: Quantitative proteomic analysis for novel biomarkers of buccal squamous cell carcinoma arising in background of oral submucous fibrosis

  Cases ANXA4 (+)(%) p value FLNA (+)(%) p value
Gender      
  Male 83 59(71.1) 0.455 57(68.7) 0.425
  Female 11 9(81.8)   5(45.5)  
Age      
  ≤40 yr 42 32(76.2) 0.453 28(66.7) 0.896
  >40 yr 52 36(69.2)   34(65.4)  
T stage      
  T1 8 3(37.5) 0.017* 2(25) 0.042*
  T2 44 29(65.9)   28(63.6)  
  T3 36 30(83.3)   27(75)  
  T4 6 6(100)   5(83.3)  
N Stage      
  N0 48 27(56.3) 0.001* 38(79.2) 0.017*
  N1 43 38(88.4)   23(53.5)  
  N2 3 3(100)   1(33.3)  
UICC Stage      
  I 7 2(28.6) 0.004* 4(57.1) 0.696
  II 31 19(61.3)   19(61.3)  
  III 50 41(82)   34(68)  
  IV 6 6(100)   5(83.3)  
Diff.      
  Well 80 59(73.8) 0.652 55(68.8) 0.180
  Moderate 10 6(60)   6(60)  
  Poor 4 3(75)   1(25)  
OSF Stage      
  Early 27 22(81.5) 0.294 16(59.3) 0.278
  Moderated 46 30(65.2)   34(73.9)  
  Advanced 21 16(76.2)   12(57.1)  
  1. * P < 0.05